CELGENE CORP /DE/
CIK 816284 · last filed 2020-07-13
CELGENE CORP /DE/ is a corporate insider who has filed 20 SEC Form 4 insider transactions across 7 companies since 2013. The most recent filing, for XLRN, was dated Jul 13, 2020. Across all open-market trades the lifetime net is +$764.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $247.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$247.64M
7
20
$764.92M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACCELERON PHARMA INC (XLRN) Delisted | 10%+ Owner | 7,008,510 | $178.75 | $1.25B | $134.50M | 7 | 2020-07-13 |
| STRO | 10%+ Owner | 1,726,197 | $28.80 | $49.71M | $0 | 1 | 2018-10-02 |
| AGIO | 10%+ Owner | 6,718,433 | $29.46 | $197.93M | $618.13M | 4 | 2018-01-31 |
| CRISPR Therapeutics AG (PZRX) Delisted | 10%+ Owner | 8,727,849 | — | — | $1.29M | 3 | 2017-12-07 |
| Alliqua BioMedical, Inc. (ALQA) Delisted | 10%+ Owner | 7,342,377 | — | — | $5.00M | 3 | 2017-04-13 |
| GLOBEIMMUNE INC (GBIM) Delisted | 10%+ Owner | 669,502 | — | — | $4.00M | 1 | 2014-07-08 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 3,267,974 | $1.47 | $4.80M | $2.00M | 1 | 2013-06-06 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-13 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | +73,476 | -$26 | EDGAR |
| 2020-07-06 | ACCELERON PHARMA INC (XLRN) Delisted | Buy (P) | +216,216 | $20.00M | EDGAR |
| 2019-01-22 | ACCELERON PHARMA INC (XLRN) Delisted | Buy (P) | +706,206 | $30.37M | EDGAR |
| 2018-10-02 | STRO | Conv (C) | +1,726,197 | $0 | EDGAR |
| 2018-01-31 | AGIO | Buy (P) | +3,404,616 | $228.11M | EDGAR |
| 2018-01-23 | AGIO | Buy (P) | +3,404,616 | $228.11M | EDGAR |
| 2017-12-07 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −1,112,446 | -$21.12M | EDGAR |
| 2017-09-25 | ACCELERON PHARMA INC (XLRN) Delisted | Buy (P) | +745,592 | $27.59M | EDGAR |
| 2017-04-24 | AGIO | Buy (P) | +2,498,300 | $123.67M | EDGAR |
| 2017-04-13 | Alliqua BioMedical, Inc. (ALQA) Delisted | Other (J) | +296,277 | $0 | EDGAR |